Baldwin, Whitney R.
Giebler, Holli A.
Stovall, Janae L.
Young, Ginger http://orcid.org/0000-0003-2403-8188
Bohning, Kelly J.
Dean, Hansi J.
Livengood, Jill A.
Huang, Claire Y.-H. http://orcid.org/0000-0002-9720-4792
Funding for this research was provided by:
CDC intramural research fund and CDC-Takeda CRADA #D-33-16 fund
Article History
Received: 25 June 2021
Accepted: 30 November 2021
First Online: 16 December 2021
Competing interests
: G.Y., K.J.B., H.J.D., J.A.L., W.R.B., and H.A.G. are employees of Takeda. H.A.G. and W.R.B. were contracted by Takeda as CDC guest researchers during the study. C.Y.H.’s laboratory received CRADA fund provided by Takeda to partly support the study. C.Y.H. is an inventor of CDC patent applications based on DENV-2 PDK-53 based chimeric flavivirus vaccines, including the D2/ZIKV and TDV vaccines (TDV is licensed to Takeda for commercial development). The remaining authors declare no competing interests.